http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0476711-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e810613c3177f1103ca8afd5eb5f0931
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 1988-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_167e8aaa392ab393f2791cd3dd5d337d
publicationDate 1992-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0476711-A2
titleOfInvention Use of 5-fluorouracil for the treatment of AIDS
abstract A therapeutic composition for combatting acquired immune deficiency syndrome (AIDS) comprising: (A) a pharmaceutically effective amount of at least one carcinostatic agent selected from alkylating agents and antimetabolites and (B) a pharmaceutically acceptable carrier.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6720136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6617157-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6617100-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6617101-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6774123-B1
priorityDate 1987-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439709
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420925
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2861016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396047
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128714525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136351332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136151018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5984
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID676166
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413356

Total number of triples: 58.